{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:52:40Z","timestamp":1781772760095,"version":"3.54.5"},"reference-count":28,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Dysphagia is a prevalent consequence of neurological conditions, particularly stroke and Parkinson\u2019s disease, leading to aspiration pneumonia and reduced quality of life. Currently, there are no specific recommendations for pharmacological therapy, although studies indicate that elevated substance P levels may improve swallowing function. While nicergoline is known to increase substance P, the role of its major metabolite, 10-methoxy-dihydro-lysergol (MDL), in this therapeutic effect remains unclear. This study examined the therapeutic effects of nicergoline and its correlation with substance P and MDL levels. Methods: This study conducted an open-label pilot study with historical controls in neurogenic patients with dysphagia. The primary outcome was improvement in the Gugging Swallowing Screen (GUSS) scores at week 12. Secondary outcomes included choking frequency, serum substance P levels, and the correlation between serum MDL levels and dysphagia enhancement. Inverse Probability Weighting (IPW) was employed to adjust for baseline confounders. Results: A total of 92 patients were analyzed: 26 in the nicergoline group (20 or 60 mg\/day) and 66 in the historical control group. Compared to controls, the nicergoline group exhibited significantly higher median of GUSS scores (20 (IQR: 19\u201320) vs. 15 (IQR: 9\u201319), p &lt; 0.001) and significantly lower median of choking frequency (6.43 (IQR 0\u201317) vs. 108 (IQR 13\u2013201) 105.22, p &lt; 0.001). The median substance P concentration in the therapy group was 4089.15 (IQR: 3336.13\u20134468.26) pg\/mL. Patients receiving nicergoline showed a statistically significant elevation in substance P from baseline (p &lt; 0.001). Pearson analysis revealed a negligible correlation between serum MDL and substance P levels (R2 = 0.0349). Conclusions: Preliminary findings suggest that nicergoline may be associated with improvements in swallowing function in neurogenic dysphagia and a potential increase in substance P levels. The lack of correlation with serum MDL suggests that efficacy may not linearly depend on circulating metabolite concentrations. Further large-scale randomized controlled trials are warranted.<\/jats:p>","DOI":"10.3390\/jcm15124728","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:33:54Z","timestamp":1781768034000},"page":"4728","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Change in Swallowing Function and Substance P Levels Associated with Nicergoline in Neurological Disease: A Pilot Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8926-4665","authenticated-orcid":false,"given":"Jutikan","family":"Imsub","sequence":"first","affiliation":[{"name":"The College of Pharmacotherapy of Thailand, Nonthaburi 11000, Thailand"},{"name":"Department of Pharmacy Practice and Pharmaceutical Care, Faculty of Pharmaceutical Science, Burapha University, Chonburi 20131, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasiri","family":"Sithinamsuwan","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine, Phramongkutklao Hospital, Bangkok 10400, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanasak","family":"Hathaiareerugand","sequence":"additional","affiliation":[{"name":"Division of Physical Medicine & Rehabilitation, Department of Medicine, Phramongkutklao Hospital, Bangkok 10400, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yarnisar","family":"Sakunchit","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine, Phramongkutklao Hospital, Bangkok 10400, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6024-8804","authenticated-orcid":false,"given":"Juthathip","family":"Suphanklang","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutical Care, Silpakorn University, Nakhon Pathom 73000, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Stampanoni Bassi, M., Centonze, D., Gjikolaj, B., Alito, A., Tisano, A., Marchese-Ragona, R., and Restivo, D.A. (2025). Neurogenic Dysphagia: Peripheral and Central Neuromodulation. Clin. Pract., 15.","DOI":"10.3390\/clinpract15090163"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s42466-021-00122-3","article-title":"Diagnosis and treatment of neurogenic dysphagia\u2014S1 guideline of the German Society of Neurology","volume":"3","author":"Dziewas","year":"2021","journal-title":"Neurol. Res. Pract."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1007\/s10072-020-04495-2","article-title":"Dysphagia in neurological diseases: A literature review","volume":"41","author":"Panebianco","year":"2020","journal-title":"Neurol. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2217\/14750708.3.2.291","article-title":"Substance P and swallowing after stroke","volume":"3","author":"Smithard","year":"2006","journal-title":"Therapy"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/PL00009592","article-title":"Lingual discoordination and dysphagia following acute stroke: Analyses of lesion localization","volume":"14","author":"Daniels","year":"1999","journal-title":"Dysphagia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2169\/internalmedicine.36.851","article-title":"New strategies for aspiration pneumonia","volume":"36","author":"Sasaki","year":"1997","journal-title":"Intern. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/archinte.1997.00440240085013","article-title":"High incidence of pneumonia in elderly patients with basal ganglia infarction","volume":"157","author":"Nakagawa","year":"1997","journal-title":"Arch. Intern. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4236\/ijcm.2013.42016","article-title":"Relationship between Dysphagia and Serum Substance P Level in Chronic Central Nervous Disease","volume":"04","author":"Kishida","year":"2013","journal-title":"Int. J. Clin. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2165\/00044011-200828090-00001","article-title":"Therapeutic use of nicergoline","volume":"28","author":"Winblad","year":"2008","journal-title":"Clin. Drug Investig."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/00023210-200014040-00003","article-title":"Nicergoline in Dementia","volume":"14","author":"Winblad","year":"2000","journal-title":"CNS Drugs"},{"key":"ref_11","first-page":"671","article-title":"Effects of nicergoline in experimental models related to pathogenesis of migraine","volume":"11","author":"Mirzoyan","year":"1989","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/MD.0b013e318224413b","article-title":"Nicergoline improves dysphagia by upregulating substance P in the elderly","volume":"90","author":"Nakashima","year":"2011","journal-title":"Medicine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000267279","article-title":"Nicergoline increases serum substance P levels in patients with an ischaemic stroke","volume":"29","author":"Nishiyama","year":"2010","journal-title":"Cerebrovasc. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"610103","DOI":"10.1155\/2014\/610103","article-title":"Safety of nicergoline as an agent for management of cognitive function disorders","volume":"2014","author":"Saletu","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_15","first-page":"33","article-title":"Effect of ergolines on neurotransmitter systems in the rat brain","volume":"294","author":"Moretti","year":"1988","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1161\/STROKEAHA.107.483933","article-title":"Dysphagia bedside screening for acute-stroke patients: The Gugging Swallowing Screen","volume":"38","author":"Trapl","year":"2007","journal-title":"Stroke"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00455-024-10717-y","article-title":"Validity and Reliability of the Swedish Version of the Gugging Swallowing Screen for use in Acute Stroke Care","volume":"40","author":"Selg","year":"2025","journal-title":"Dysphagia"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Jiang, Y., Chi, Y., Pan, R., Zhang, D., Huang, S., Ju, H., and Li, Y. (2024). Advancing stroke patient care: A network meta-analysis of dysphagia screening efficacy and personalization. Front. Neurol., 15.","DOI":"10.3389\/fneur.2024.1380287"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s41999-019-00249-2","article-title":"The GUSS test as a good indicator to evaluate dysphagia in healthy older people: A multicenter reliability and validity study","volume":"10","author":"Umay","year":"2019","journal-title":"Eur. Geriatr. Med."},{"key":"ref_20","unstructured":"Abcam (2024). Substance P ELISA Kit Protocol (ab288318), Abcam."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0378-4347(91)80175-C","article-title":"Assay of nicergoline and three metabolites in human plasma and urine by high-performance liquid chromatography-atmospheric pressure ionization mass spectrometry","volume":"568","author":"Banno","year":"1991","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jpha.2011.09.005","article-title":"Determination of metabolite of nicergoline in human plasma by high-performance liquid chromatography and its application in pharmacokinetic studies","volume":"2","author":"Zheng","year":"2012","journal-title":"J. Pharm. Anal."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/STROKEAHA.116.015434","article-title":"Using the National Institutes of Health Stroke Scale: A Cautionary Tale","volume":"48","author":"Lyden","year":"2017","journal-title":"Stroke"},{"key":"ref_24","first-page":"S171","article-title":"Establishment of the Thai version of National Institute of Health Stroke Scale (NIHSS) and a validation study","volume":"93","author":"Nilanont","year":"2010","journal-title":"J. Med. Assoc. Thail."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: Onset, progression, and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3928\/00220124-20150220-12","article-title":"Using the gugging swallowing screen (GUSS) for dysphagia screening in acute stroke patients","volume":"46","author":"John","year":"2015","journal-title":"J. Contin. Educ. Nurs."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Carbonell-Rozas, L., G\u00e1miz-Gracia, L., Lara, F.J., and Garc\u00eda-Campa\u00f1a, A.M. (2021). Determination of the Main Ergot Alkaloids and Their Epimers in Oat-Based Functional Foods by Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry. Molecules, 26.","DOI":"10.3390\/molecules26123717"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1021\/acs.jafc.6b02484","article-title":"Simultaneous Determination of 25 Ergot Alkaloids in Cereal Samples by Ultraperformance Liquid Chromatography-Tandem Mass Spectrometry","volume":"64","author":"Guo","year":"2016","journal-title":"J. Agric. Food Chem."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4728\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:09:11Z","timestamp":1781770151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jcm15124728"],"URL":"https:\/\/doi.org\/10.3390\/jcm15124728","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]}}}